TCS, HDFCBANK, SBI Liquid Fund (G)
Jagsonpal Pharmaceuticals Ltd.
Jagsonpal Pharma
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 25 05 2021 | Inter alia, to consider and approve investment in the associate company along with other routine matters. |
| 30 06 2021 | A.G.M. & Dividend & Audited Results |
| 13 08 2021 | Quarterly Results |
| 19 10 2021 | Quarterly Results & Interim Dividend |
| 27 01 2022 | JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2022 ,inter alia, to consider and approve unaudited financial results for the quarter and nine months ended 31.December.2021. |
| 11 02 2022 | Quarterly Results |
| 13 05 2022 | Inter alia, to consider and approve the alteration in AOA and other routine matters. |
| 30 05 2022 | Audited Results & Quarterly Results |
| 09 08 2022 | Quarterly Results |
| 09 11 2022 | Quarterly Results |
| 08 02 2023 | Quarterly Results |
| 23 05 2023 | Dividend & Audited Results |
| 02 08 2023 | Quarterly Results |
| 03 11 2023 | Quarterly Results |
| 02 02 2024 | Quarterly Results |
| 23 10 2024 | Stock Split & Quarterly Results |
| 22 01 2025 | Quarterly Results |
News
No News data available
